VPS54
Basic information
Region (hg38): 2:63892146-64019428
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VPS54 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 40 | 42 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 41 | 1 | 2 |
Variants in VPS54
This is a list of pathogenic ClinVar variants found in the VPS54 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-63893491-G-T | not specified | Uncertain significance (May 20, 2024) | ||
2-63893506-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
2-63897588-C-A | not specified | Benign (-) | ||
2-63899588-G-A | Benign (Aug 20, 2018) | |||
2-63912336-A-T | Likely benign (-) | |||
2-63912577-T-C | not specified | Uncertain significance (Aug 17, 2022) | ||
2-63912610-C-T | not specified | Uncertain significance (Nov 27, 2023) | ||
2-63913259-C-G | not specified | Uncertain significance (Jun 28, 2023) | ||
2-63914195-G-A | not specified | Uncertain significance (May 30, 2024) | ||
2-63914230-G-C | not specified | Uncertain significance (Jul 14, 2021) | ||
2-63916886-A-T | not specified | Benign (-) | ||
2-63916887-A-C | not specified | Benign (-) | ||
2-63916934-G-C | not specified | Uncertain significance (Jul 12, 2022) | ||
2-63920467-T-C | not specified | Uncertain significance (Aug 10, 2021) | ||
2-63920541-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
2-63920551-G-C | Uncertain significance (Jan 01, 2017) | |||
2-63920564-A-G | not specified | Uncertain significance (Dec 14, 2023) | ||
2-63921211-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
2-63921228-T-C | not specified | Uncertain significance (Dec 13, 2022) | ||
2-63921237-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
2-63921305-T-C | Uncertain significance (May 01, 2016) | |||
2-63933691-G-C | Uncertain significance (Aug 01, 2017) | |||
2-63933709-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
2-63933730-G-C | Benign (Jul 23, 2018) | |||
2-63933817-A-G | not specified | Uncertain significance (Dec 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VPS54 | protein_coding | protein_coding | ENST00000272322 | 22 | 126927 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000706 | 125714 | 0 | 17 | 125731 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.951 | 425 | 484 | 0.878 | 0.0000229 | 6419 |
Missense in Polyphen | 78 | 153.68 | 0.50756 | 2062 | ||
Synonymous | -0.374 | 177 | 171 | 1.04 | 0.00000846 | 1804 |
Loss of Function | 5.77 | 7 | 51.8 | 0.135 | 0.00000256 | 691 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000162 | 0.000155 |
Ashkenazi Jewish | 0.000100 | 0.0000993 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.000139 | 0.0000924 |
European (Non-Finnish) | 0.0000897 | 0.0000879 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as component of the GARP complex that is involved in retrograde transport from early and late endosomes to the trans-Golgi network (TGN). The GARP complex is required for the maintenance of the cycling of mannose 6-phosphate receptors between the TGN and endosomes, this cycling is necessary for proper lysosomal sorting of acid hydrolases such as CTSD (PubMed:18367545). Within the GARP complex, required to tether the complex to the TGN. Not involved in endocytic recycling (PubMed:25799061). {ECO:0000269|PubMed:18367545, ECO:0000269|PubMed:25799061}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.610
- rvis_EVS
- -0.91
- rvis_percentile_EVS
- 10.07
Haploinsufficiency Scores
- pHI
- 0.257
- hipred
- Y
- hipred_score
- 0.653
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.105
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vps54
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- Golgi to vacuole transport;lysosomal transport;protein transport;regulation of growth;retrograde transport, endosome to Golgi;homeostasis of number of cells within a tissue;musculoskeletal movement;neurofilament cytoskeleton organization
- Cellular component
- GARP complex;nucleoplasm;Golgi apparatus;trans-Golgi network;cytosol;trans-Golgi network membrane;perinuclear region of cytoplasm
- Molecular function
- protein binding;syntaxin binding